Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
54.84 USD | +1.92% | +2.18% | -12.30% |
Apr. 18 | Citigroup Adjusts CRISPR Therapeutics' Price Target to $89 From $88, Keeps Buy Rating | MT |
Apr. 17 | Crispr Therapeutics Insider Sold Shares Worth $1,173,232, According to a Recent SEC Filing | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- CRSP Stock
- News CRISPR Therapeutics AG
- Official Publications